Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-07-11 19:55 | 2014-07-10 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $83.40 | 14,000 | $1,167,583 | 11,035,682 |
| 2014-07-12 00:34 | 2014-07-09 | BAX | BAXTER INTERNATIONAL INC | HANTSON LUDWIG | Officer | OPT+S | $76.00 | 24,693 | $1,876,668 | 83,903 |
| 2014-07-09 23:27 | 2014-07-08 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $83.94 | 14,000 | $1,175,121 | 11,049,682 |
| 2014-07-09 21:51 | 2014-07-07 | CTSO | Cytosorbents Corp | Kraus Al | Director | OPT+S | $0.24 | 50,000 | $11,750 | 1,393,631 |
| 2014-07-10 01:49 | 2014-07-08 | DXCM | DEXCOM INC | VALDES JORGE A | Officer | OPT+S | $36.66 | 16,000 | $586,506 | 217,487 |
| 2014-07-08 19:07 | 2014-07-07 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | OPT+S | $35.97 | 5,837 | $209,978 | 14,901 |
| 2014-07-07 20:54 | 2014-07-07 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $85.19 | 7,000 | $596,297 | 11,063,682 |
| 2014-07-07 23:44 | 2014-07-03 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $50.04 | 5,000 | $250,200 | 69,207 |
| 2014-07-03 22:24 | 2014-07-01 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $35.83 | 4,600 | $164,798 | 130,307 |
| 2014-07-03 19:43 | 2014-07-02 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $85.37 | 14,000 | $1,195,201 | 11,070,682 |
| 2014-07-03 16:52 | 2014-07-01 | RMD | RESMED INC | FARRELL PETER C | Director | OPT+S | $50.09 | 25,000 | $1,252,250 | 304,990 |
| 2014-07-03 23:34 | 2014-07-01 | DXCM | DEXCOM INC | SKYLER JAY S | Director | SELL | $40.05 | 30,000 | $1,201,404 | 115,884 |
| 2014-07-02 21:01 | 2014-06-30 | VYCO | VYCOR MEDICAL INC | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | 10% owner | BUY | $1.80 | 6,329 | $11,392 | 4,352,081 |
| 2014-07-03 00:06 | 2014-06-30 | MDXG | MIMEDX GROUP, INC. | Taylor William Charles | Director, Officer | OPT+S | $7.50 | 150,000 | $1,125,000 | 359,506 |
| 2014-07-03 02:40 | 2014-07-01 | TNDM | TANDEM DIABETES CARE INC | Sheridan John F | Officer | OPT+S | $16.42 | 2,000 | $32,837 | 1,198 |
| 2014-07-03 03:11 | 2014-07-01 | RMD | RESMED INC | Douglas Robert Andrew | Officer | OPT+S | $50.11 | 8,000 | $400,880 | 97,771 |
| 2014-07-02 23:05 | 2014-07-01 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | OGRADY JUDITH | Officer | SELL | $47.54 | 2,500 | $118,849 | 15,706 |
| 2014-07-02 23:16 | 2014-07-01 | BSX | BOSTON SCIENTIFIC CORP | MARIO ERNEST | Director | SELL | $12.95 | 10,000 | $129,468 | 297,855 |
| 2014-07-03 00:54 | 2014-06-30 | CTSO | Cytosorbents Corp | Kraus Al | Director | OPT+S | $0.24 | 50,000 | $11,800 | 1,393,631 |
| 2014-07-02 23:54 | 2014-07-01 | PODD | INSULET CORP | DeSisto Duane | Director, Officer | OPT+S | $40.52 | 20,000 | $810,336 | 257,184 |
| 2014-07-02 23:44 | 2014-07-01 | PODD | INSULET CORP | Diehl R Anthony | Officer | OPT+S | $39.65 | 1,250 | $49,563 | 47,875 |
| 2014-07-02 23:42 | 2014-06-30 | PODD | INSULET CORP | SOBIESKI STEVEN | Director | SELL | $40.00 | 8,000 | $320,000 | 12,000 |
| 2014-07-01 22:44 | 2014-06-30 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $84.97 | 14,000 | $1,189,643 | 11,084,682 |
| 2014-04-01 00:23 | 2014-03-31 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $59.83 | 15,000 | $897,450 | 450,235 |
| 2014-03-31 23:22 | 2014-03-27 | BAX | BAXTER INTERNATIONAL INC | Bufalino Sebastian J | Officer | OPT+S | $75.10 | 21,600 | $1,622,160 | 6,275 |
| 2014-03-29 03:30 | 2014-03-26 | DXCM | DEXCOM INC | SKYLER JAY S | Director | SELL | $43.05 | 30,000 | $1,291,458 | 235,884 |
| 2014-03-26 21:54 | 2014-03-24 | SYK | STRYKER CORP | Benscoter Steven P | Officer | SELL | $79.63 | 1,789 | $142,455 | 8,302 |
| 2014-03-26 23:43 | 2014-03-25 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $43.00 | 10,000 | $429,964 | 159,099 |
| 2014-03-26 23:43 | 2014-03-24 | DXCM | DEXCOM INC | Pacelli Steven Robert | Officer | OPT+S | $42.92 | 14,000 | $600,814 | 241,399 |
| 2014-03-26 00:09 | 2014-03-25 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $59.13 | 6,696 | $395,947 | 450,235 |
| 2014-03-25 01:35 | 2014-03-24 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $59.20 | 18,304 | $1,083,632 | 450,235 |
| 2014-03-21 00:25 | 2014-03-18 | DXCM | DEXCOM INC | ROPER JESS | Officer | OPT+S | $46.00 | 8,000 | $368,000 | 87,786 |
| 2014-03-19 18:38 | 2014-03-17 | SNWV | SANUWAVE Health, Inc. | Chiarelli Joseph | Director, Officer | BUY | $0.50 | 80,000 | $40,000 | 121,667 |
| 2014-03-18 23:08 | 2014-03-17 | BSX | BOSTON SCIENTIFIC CORP | Phalen Michael P. | Officer | OPT+S | $13.05 | 13,500 | $176,110 | 127,486 |
| 2014-03-19 00:33 | 2014-03-17 | INFU | InfuSystem Holdings, Inc | Morris Ryan J. | Director, Officer | OPT+S | $2.90 | 24,600 | $71,264 | 1,487,850 |
| 2014-03-19 00:53 | 2014-03-17 | SNWV | SANUWAVE Health, Inc. | Richardson Kevin A II | Director, 10% owner | BUY | $0.50 | 100,000 | $50,000 | 157,500 |
| 2014-03-19 00:37 | 2014-03-18 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $58.83 | 6,600 | $388,299 | 450,235 |
| 2014-03-18 02:02 | 2014-03-06 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $8.16 | 8,000 | $65,301 | 707 |
| 2014-03-18 02:01 | 2014-03-03 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | SELL | $8.20 | 6,371 | $52,242 | 707 |
| 2014-03-18 03:28 | 2014-03-13 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | OPT+S | $45.25 | 45,000 | $2,036,246 | 702,889 |
| 2014-03-18 03:10 | 2014-03-13 | DXCM | DEXCOM INC | LORD JONATHAN T MD | Director | OPT+S | $45.05 | 36,000 | $1,621,800 | 128,310 |
| 2014-03-18 01:37 | 2014-03-17 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $58.53 | 18,400 | $1,076,956 | 450,235 |
| 2014-03-14 22:57 | 2014-03-13 | INFU | InfuSystem Holdings, Inc | Foster Jonathan P. | Officer | BUY | $2.78 | 5,000 | $13,900 | 5,000 |
| 2014-03-15 01:39 | 2014-03-13 | UTMD | UTAH MEDICAL PRODUCTS INC | HOYER ERNST G | Director | SELL | $56.04 | 1,486 | $83,280 | 32,358 |
| 2014-03-14 23:41 | 2014-03-12 | LMAT | LEMAITRE VASCULAR INC | LeMaitre Cornelia W | Director, Officer | SELL | $8.30 | 100 | $830 | 403,837 |
| 2014-03-15 03:51 | 2014-03-12 | DXCM | DEXCOM INC | LISTER JOHN | Officer | OPT+S | $45.25 | 9,158 | $414,432 | 120,542 |
| 2014-03-14 02:28 | 2014-03-11 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | OPT+S | $45.50 | 30,000 | $1,365,087 | 395,626 |
| 2014-03-14 02:20 | 2014-03-11 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Officer | OPT+S | $46.42 | 50,000 | $2,321,245 | 152,443 |
| 2014-03-14 02:12 | 2014-03-11 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $45.93 | 10,000 | $459,267 | 167,907 |
| 2014-03-14 02:09 | 2014-03-11 | DXCM | DEXCOM INC | VALDES JORGE A | Officer | OPT+S | $46.18 | 23,437 | $1,082,328 | 203,003 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.